TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2015

Flu-like and Other Systemic Drug Reactions Among Persons Receiving Weekly Rifapentine Plus Isoniazid or Daily Isoniazid for Treatment of Latent Tuberculosis Infection in the PREVENT Tuberculosis Study.

Timothy R Sterling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.